Eric Lim
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Eric Lim
May 15, 2024, 11:40 |
Insight
Eric Lim: Extended pleurectomy decortication for mesothelioma resulted in shorter survival
Eric Lim, Consultant Thoracic Surgeon at Royal Brompton and Harefield Hospitals, shared on X: "MARS 2…
May 14, 2024, 13:53 |
Blog
John Edwards: Lots of debate about the MARS2 RCT of mesothelioma surgery since Eric Lim’s presentation at IASLC
John Edwards, Consultant Thoracic Surgeon at Sheffield Teaching Hospitals NHS Foundation Trust and Member Board…
Apr 21, 2024, 07:25 |
Insight
Gerry Hanna: Key take home is that there is no place for surgical resection in mesothelioma
Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared on X…
Sep 12, 2023, 15:20 |
Blog
Chul Kim: Reflecting further on MARS 2, its remarkable qualities stand out in several ways.
Chul Kim, Thoracic Medical Oncologist at Georgetown University, made the following post on Twitter: "Reflecting…
Sep 11, 2023, 18:17 |
Blog
Stephen V Liu: Dr. Eric Lim's presentation of MARS2 was the best presentation I think I have ever seen.
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube